1. Academic Validation
  2. O-GlcNAcylation regulates the stability and enzymatic activity of the histone methyltransferase EZH2

O-GlcNAcylation regulates the stability and enzymatic activity of the histone methyltransferase EZH2

  • Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):7302-7307. doi: 10.1073/pnas.1801850115.
Pei-Wen Lo 1 Jiun-Jie Shie 2 Chein-Hung Chen 1 Chung-Yi Wu 1 Tsui-Ling Hsu 1 Chi-Huey Wong 3
Affiliations

Affiliations

  • 1 Genomics Research Center, Academia Sinica, Taipei 115, Taiwan.
  • 2 Institute of Chemistry, Academia Sinica, Taipei 115, Taiwan.
  • 3 Genomics Research Center, Academia Sinica, Taipei 115, Taiwan; [email protected].
Abstract

Protein O-glycosylation by attachment of β-N-acetylglucosamine (GlcNAc) to the Ser or Thr residue is a major posttranslational glycosylation event and is often associated with protein folding, stability, and activity. The methylation of histone H3 at Lys-27 catalyzed by the methyltransferase EZH2 was known to suppress gene expression and Cancer development, and we previously reported that the O-GlcNAcylation of EZH2 at S76 stabilized EZH2 and facilitated the formation of H3K27me3 to inhibit tumor suppression. In this study, we employed a fluorescence-based method of sugar labeling combined with mass spectrometry to investigate EZH2 glycosylation and identified five O-GlcNAcylation sites. We also find that mutation of one or more of the O-GlcNAcylation sites S73A, S76A, S84A, and T313A in the N-terminal region decreases the stability of EZH2, but does not affect its association with the PRC2 components SUZ12 and EED. Mutation of the C-terminal O-GlcNAcylation site (S729A) in the catalytic domain of EZH2 abolishes the di- and trimethylation activities, but not the monomethylation of H3K27, nor the integrity of the PRC2/EZH2 core complex. Our results show the effect of individual O-GlcNAcylation sites on the function of EZH2 and suggest an alternative approach to tumor suppression through selective inhibition of EZH2 O-GlcNAcylation.

Keywords

H3K27me3; O-GlcNAcylation; cancer; methyltransferase EZH2.

Figures
Products